Jefferies LLC

Please note: The information displayed on this page might be outdated.
Jefferies LLC: Jefferies, LLC is a full-service global investment bank that offers equity research services to institutional investors. The firm also offers broker/dealer services, corporate finance, institutional sales/trading, and asset management services. In late 2002, Jefferies & Company (U.S.) acquired Quarterdeck Investment Partners, a middle-market boutique investment banking firm specializing in mergers and acquisitions. The firm was founded in 1962 by Boyd Jefferies and is headquartered in New York and has offices worldwide. Jefferies Bache Securities, LLC has merged into the Jefferies & Company, Inc. broker/dealer in November 2011. Leucadia National Corporation acquired Jefferies Group, LLC on March 1, 2013, onthe same day Jefferies & Company (U.S.) changed its name to Jefferies, LLC.
Sector/Industry:
Financial Services/Diversified Financial Services
Characteristics:
Based in...
US - Middle Atlantic
Listing
Public, USA
Market Cap
1B +
Website:
Profiles:
Address:
520 Madison Avenue
New York, NY 10022
United States

Company Participants at 2020 Wall Street "On Tap"

Gil Bar-Nahum
Jefferies LLC, Managing Director
Dr. Gil Bar-Nahum is a Managing Director in the Global Healthcare Investment Banking Group and leads the International Biotechnology effort at Jefferies. Dr. Bar-Nahum has over 17 years of experience and was an Executive Director in UBS Investment Bank's Global Healthcare Group until 2009. Prior to that, Dr. Bar-Nahum worked as a Biotechnology Research Analyst for UBS where he served as an Associate Director covering companies in the Life Sciences space. Dr. Bar-Nahum has executed and advised on over 100 transactions in the life sciences space, with particular expertise in Biotechnology Mergers and Acquisitions, and in raising capital for highly innovative developmental stage growth companies. In the last several years, Dr. Bar-Nahum has led follow-on financings and Initial Public offerings of numerous international Biotechnology Companies, including 10 foreign private issuers onto NASDAQ, raising north of $2bn in proceeds. Dr. Bar-Nahum received his PhD in biochemistry from the Sackler Institute at the New York University School of Medicine. The subject of Dr. Bar-Nahum's doctorate work was published twice in the journal Cell. Dr. Bar- Nahum also received an MS from New York University.

Top 10 Holders of Jefferies Financial Group Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
The Vanguard Group, Inc. 7.25 20,653,396 540.29 Funds 12/31/20
Vanguard Group, Inc. (Subfiler) 7.07 20,121,855 526.39 13F 9/30/20
First Pacific Advisors LP 6.05 17,221,091 450.50 13F 9/30/20
Baillie Gifford & Co. 4.42 12,580,716 329.11 13F 9/30/20
Barrow, Hanley, Mewhinney & Strauss LLC 3.40 9,683,360 253.32 13F 9/30/20
BlackRock Fund Advisors 3.31 9,414,332 246.28 13F 9/30/20
BlackRock Institutional Trust Co. NA 2.39 6,818,387 178.37 13F 9/30/20
Burgundy Asset Management Ltd. 1.95 5,543,495 145.02 13F 9/30/20
State Street Corp. 1.78 5,061,360 132.41 13F 9/30/20
Arrowstreet Capital LP 1.35 3,833,864 100.29 13F 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.